A Phase I Clinical Trial to Evaluate the Bioequivalence of an Adalimumab Biosimilar Adalimumab-WIBP and Humira®.
Hu S, Liu Y, Yang L, Yang Y, Long F, Bao H, Zhang H, Yue X, Zhang J, Wang Z, Huang C, Wang J, Xia L, Pan Y, Zhang Y, Gong F.
Hu S, et al. Among authors: pan y.
Clin Drug Investig. 2024 Nov 15. doi: 10.1007/s40261-024-01409-4. Online ahead of print.
Clin Drug Investig. 2024.
PMID: 39546188